[{"address1": "1000 Skokie Boulevard", "address2": "Suite 350", "city": "Wilmette", "state": "IL", "zip": "60091", "country": "United States", "phone": "847 388 0349", "website": "https://www.monopartx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, a clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. It develops MNPR-101-Lu, a late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225. The company has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19. The company was founded in 2014 and is headquartered in Wilmette, Illinois.", "fullTimeEmployees": 14, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christopher M. Starr Ph.D.", "age": 73, "title": "Co-Founder & Independent Executive Chairman of the Board", "yearBorn": 1952, "fiscalYear": 2024, "totalPay": 200000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chandler D. Robinson M.B.A., M.D., M.Sc.", "age": 41, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1984, "fiscalYear": 2024, "totalPay": 1144480, "exercisedValue": 0, "unexercisedValue": 760281}, {"maxAge": 1, "name": "Mr. Andrew J. Cittadine M.B.A.", "age": 53, "title": "Chief Operating Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 542544, "exercisedValue": 0, "unexercisedValue": 179487}, {"maxAge": 1, "name": "Mr. Quan Anh Vu", "age": 56, "title": "CFO, Principal accounting officer & Principal financial officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Patrice P. Rioux M.D., Ph.D.", "age": 74, "title": "Acting Chief Medical Officer", "yearBorn": 1951, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 10, "compensationRisk": 9, "shareHolderRightsRisk": 2, "overallRisk": 8, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 67.34, "open": 67.0, "dayLow": 60.28, "dayHigh": 67.05, "regularMarketPreviousClose": 67.34, "regularMarketOpen": 67.0, "regularMarketDayLow": 60.28, "regularMarketDayHigh": 67.05, "payoutRatio": 0.0, "beta": 1.473, "forwardPE": -17.336975, "volume": 283835, "regularMarketVolume": 283835, "averageVolume": 248203, "averageVolume10days": 319310, "averageDailyVolume10Day": 319310, "bid": 65.74, "ask": 61.39, "bidSize": 4, "askSize": 1, "marketCap": 403494432, "fiftyTwoWeekLow": 26.055, "fiftyTwoWeekHigh": 105.0, "allTimeHigh": 240.0, "allTimeLow": 1.37, "fiftyDayAverage": 72.8411, "twoHundredDayAverage": 56.780327, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 259920864, "profitMargins": 0.0, "floatShares": 4219384, "sharesOutstanding": 6682584, "sharesShort": 1279274, "sharesShortPriorMonth": 822858, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.19139999, "heldPercentInsiders": 0.23947, "heldPercentInstitutions": 0.66454005, "shortRatio": 3.99, "shortPercentOfFloat": 0.5113, "impliedSharesOutstanding": 6682584, "bookValue": 21.246, "priceToBook": 2.8419468, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -19441708, "trailingEps": -3.56, "forwardEps": -3.48273, "lastSplitFactor": "1:5", "lastSplitDate": 1723507200, "52WeekChange": 0.38645232, "SandP52WeekChange": 0.1575526, "quoteType": "EQUITY", "currentPrice": 60.38, "targetHighPrice": 130.0, "targetLowPrice": 93.0, "targetMeanPrice": 112.0, "targetMedianPrice": 112.0, "recommendationMean": 1.28571, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 14, "totalCash": 143675792, "totalCashPerShare": 21.5, "totalDebt": 102236, "quickRatio": 55.937, "currentRatio": 56.098, "debtToEquity": 0.072, "returnOnAssets": -0.17988001, "returnOnEquity": -0.26541, "freeCashflow": -8453437, "operatingCashflow": -10829637, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MNPR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "exchange": "NCM", "messageBoardId": "finmb_304391755", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -10.335604, "regularMarketPrice": 60.38, "shortName": "Monopar Therapeutics Inc.", "longName": "Monopar Therapeutics Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1576765800000, "postMarketChangePercent": -0.79496443, "postMarketPrice": 59.9, "postMarketChange": -0.47999954, "regularMarketChange": -6.9599953, "regularMarketDayRange": "60.28 - 67.05", "priceEpsCurrentYear": -36.1038, "fiftyDayAverageChange": -12.461102, "fiftyDayAverageChangePercent": -0.1710724, "twoHundredDayAverageChange": 3.5996742, "twoHundredDayAverageChangePercent": 0.063396506, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1769810645, "regularMarketTime": 1769806802, "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 248203, "fiftyTwoWeekLowChange": 34.325, "fiftyTwoWeekLowChangePercent": 1.3174055, "fiftyTwoWeekRange": "26.055 - 105.0", "fiftyTwoWeekHighChange": -44.62, "fiftyTwoWeekHighChangePercent": -0.42495236, "fiftyTwoWeekChangePercent": 38.645233, "earningsTimestamp": 1763040600, "earningsTimestampStart": 1763040600, "earningsTimestampEnd": 1763040600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -3.56, "epsForward": -3.48273, "epsCurrentYear": -1.6724, "displayName": "Monopar Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-31"}]